ARCHIVES

Xgeva Significantly Increases Bone Metastasis-Free Survival

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

BRMP Proposals for Thymosins Development

November 30, 1979

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

September 11, 1998

Clolar Approved for Pediatric Refractory/Relapsed ALL

January 28, 2005

Automated Thermography System Said to Be As Good As Mammography Developed for Mass Screening

July 4, 1980

RFP: Intellectual Property.

March 31, 2000

Healy Attacks Scripps-Sandoz Research Deal, Rep. Wyden Asks For HHS Investigation

March 19, 1993